NM_006949.4:c.495C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006949.4(STXBP2):​c.495C>T​(p.Arg165Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,552,168 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 12 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 108 hom. )

Consequence

STXBP2
NM_006949.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.671

Publications

6 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-7641770-C-T is Benign according to our data. Variant chr19-7641770-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0509 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.495C>T p.Arg165Arg synonymous_variant Exon 7 of 19 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.495C>T p.Arg165Arg synonymous_variant Exon 7 of 19 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*598C>T non_coding_transcript_exon_variant Exon 9 of 20 ENSP00000513686.1 A0A8V8TM65
ENSG00000268400ENST00000698368.1 linkn.*598C>T 3_prime_UTR_variant Exon 9 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.00303
AC:
461
AN:
152188
Hom.:
12
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0548
Gnomad SAS
AF:
0.0232
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00750
AC:
1182
AN:
157622
AF XY:
0.00804
show subpopulations
Gnomad AFR exome
AF:
0.000786
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0597
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000818
Gnomad OTH exome
AF:
0.00584
GnomAD4 exome
AF:
0.00291
AC:
4071
AN:
1399862
Hom.:
108
Cov.:
32
AF XY:
0.00334
AC XY:
2306
AN XY:
690606
show subpopulations
African (AFR)
AF:
0.000506
AC:
16
AN:
31646
American (AMR)
AF:
0.000140
AC:
5
AN:
35836
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25174
East Asian (EAS)
AF:
0.0528
AC:
1898
AN:
35920
South Asian (SAS)
AF:
0.0215
AC:
1703
AN:
79296
European-Finnish (FIN)
AF:
0.0000203
AC:
1
AN:
49362
Middle Eastern (MID)
AF:
0.00189
AC:
9
AN:
4770
European-Non Finnish (NFE)
AF:
0.0000657
AC:
71
AN:
1079882
Other (OTH)
AF:
0.00633
AC:
367
AN:
57976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
285
570
854
1139
1424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00301
AC:
458
AN:
152306
Hom.:
12
Cov.:
33
AF XY:
0.00349
AC XY:
260
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41574
American (AMR)
AF:
0.000523
AC:
8
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0543
AC:
281
AN:
5172
South Asian (SAS)
AF:
0.0232
AC:
112
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68010
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000706
Hom.:
2
Bravo
AF:
0.00263
Asia WGS
AF:
0.0380
AC:
132
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 25, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32517705) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.9
DANN
Benign
0.37
PhyloP100
0.67
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2303116; hg19: chr19-7706656; COSMIC: COSV55401727; COSMIC: COSV55401727; API